Millennium Management’s BeOne Medicines Ltd ONC Stock Holding History

Millennium Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.56M	Buy	+12,500	New	+$3.68M	﹤0.01%	3318
2026 Q1	–	Sell	-20,000	Closed	-$6.08M	–	6539
2025 Q4	$6.08M	Sell	20,000 -30,000	-60%	-$9.82M	﹤0.01%	2798
2025 Q3	$17M	Buy	+50,000	New	+$15.2M	0.01%	1837
2020 Q1	–	Sell	-25,000	Closed	-$4.14M	–	4613
2019 Q4	$4.14M	Buy	+25,000	New	+$4.15M	0.01%	2082

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management's ONC Position: Q2 2026 in Review

Millennium Management increased its BeOne Medicines Ltd (ONC) stake by 165% in Q2 2026, buying an estimated $99.7M and bringing the position to 543,323 shares worth $155M. The position accounts for 0.06% of the portfolio, ranked #331.

Millennium Management first reported a position in ONC in Q1 2016 and has held it in 32 quarters since. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Millennium Management held 543,323 shares of BeOne Medicines Ltd worth $155M as of Q2 2026.
Millennium Management bought 338,477 BeOne Medicines Ltd shares in Q2 2026, an estimated $99.7M.
BeOne Medicines Ltd made up 0.06% of Millennium Management's portfolio in Q2 2026, its #331 holding.
Millennium Management first reported a position in BeOne Medicines Ltd in Q1 2016 and has held it in 32 quarters since.
283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.